Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Epilim 100 Crushable
Sodium valproate 100mg
Tablet
sanofi-aventis new zealand limited
Sanofi-Synthelabo Limited, Tyne & Wear, United Kingdom
Sanofi India Limited, Goa, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Epilim EC
Sodium valproate 200mg
Modified release tablet
sanofi-aventis new zealand limited
Sanofi-Synthelabo Limited, Tyne & Wear, United Kingdom
Sanofi India Limited, Goa, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Epilim EC
Sodium valproate 500mg
Modified release tablet
sanofi-aventis new zealand limited
Sanofi-Synthelabo Limited, Tyne & Wear, United Kingdom
Sanofi India Limited, Goa, India
|
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
NeisVac-C
Neisseria meningitidis Group C polysaccharide 10mcg
Tetanus toxoid 10mcg
Suspension for injection
Baxter Healthcare Limited
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America
Baxter AG, Vienna, Austria
|
Dated this 5th day of February 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz